Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Advalytix
Advalytix Announces Study of Single Circulating Tumor Cells with the M. D. Anderson Cancer Center
September 26th, 2008
The Advalytix product team of Olympus is initiating a collaborative study with The University of Texas M. D. Anderson Cancer Center to characterize circulating tumor cells in breast cancer patients. The study combines Advalytix's sensitive AmpliGrid molecular analysis platform, multiplex primer design, and integrated workflow to analyze expression of multiple target genes in single tumor cells. "Using AmpliGrid, we plan to genetically fingerprint subpopulations of tumor cells with a convenient workflow," said Dr. James Reuben, Associate Professor at M. D. Anderson Cancer Center. "The goal is to develop powerful tools to monitor...
Source: Health Business Week (2008-09-26)
|
